Advances have already been made in studies of group differences under baseline conditions in studies of human patients, which found reduced levels of HDAC2 and altered methylation of DNMT3L genes in PTSD (Uddin et al., 2010; Sun et al., 2013). The gene discussed is HDAC2; the disease is post-traumatic stress disorder.